OPY Acquisition Corp. I (OHAAU) Prices Upsized $110M IPO

OPY Acquisition Corp. I  announced the pricing of its upsized $110 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “OHAAU” Wednesday, October 27.

The new SPAC intends to focus on companies in the life sciences industry with a primary focus on novel therapeutics, medical devices, or services that help improve healthcare outcomes. OPY Acquisition Corp. I is led by Chairman and CEO Jonathan B. Siegel, and CFO Daniel E. Geffken.

Total SPAC deal count for 2021 year-to-date is now 494. This offering is expected to close on Friday, October 29.

Oppenheimer & Co. and Lake Street are serving as the joint book-running managers for the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with White & Case LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.